8770 BRYN MAWR AVE STE 1300, Chicago, IL, 60631-3557
Amount:$1,499,949.00
DUNS:078496768
HUBZone Owned:N
Woman Owned:N
Socially and Economically Disadvantaged:N
Principal Investigator
Name: ERIK FORSBERG
Phone: (608) 334-7876
Email: eforsberg@regenmedsolutions.com
Phone: (608) 334-7876
Email: eforsberg@regenmedsolutions.com
Business Contact
Name: ERIK FORSBERG
Phone: (608) 334-7876
Email: eforsberg@regenmedsolutions.com
Phone: (608) 334-7876
Email: eforsberg@regenmedsolutions.com
Research Institution
N/A
Amount:$238,328.00
Phase:Phase I
Program:SBIR
Awards Year:2017
Solicitation Year:2015
Solicitation Topic Code:NIAID
Solicitation Number:PA15-269
1928 SW 36TH PL, Gainesville, FL, 32608-3436
DUNS:004095863
HUBZone Owned:N
Woman Owned:N
Socially and Economically Disadvantaged:N
Principal Investigator
Name: GREGORY MARSHALL
Phone: (352) 871-4074
Email: gpm2@ufl.edu
Phone: (352) 871-4074
Email: gpm2@ufl.edu
Business Contact
Name: TODD BRUSKO
Phone: (352) 273-9255
Email: tbrusko@ufl.edu
Phone: (352) 273-9255
Email: tbrusko@ufl.edu
Research Institution
N/A
Company Information
Address
8310 Commerce Way #155
Miami, FL, 33016-1613
funding 2.8 million
Information
DUNS: 963370148
# of Employees: 2
Preclinical characterization of THR to induce pancreatic beta cell regeneration Phase I
Amount: $223,876.00The exocrine acinar ductal compartment of the pancreas has been hypothesized to harbor progenitor cells with the ability to give rise to new b cells The activation of such progenitors may potential ...SBIRPhase I2017Department of Health and Human Services National Institutes of HealthtechnologyIn vitro maturation of BMP responsive pancraeatic beta cell progenitors by oxygen modulation
Amount: $1,443,038.00PROJECT SUMMARY Islet transplantation represents the current cell therapy standard for type diabetes T D However the gap between the availability of donor organs and the clinical demand for the ...SBIRPhase II2016Department of Health and Human Services National Institutes of HealthIn vitro maturation of BMP-7-responsive pancreatic beta cell progenitors by oxygen modulation technology
Amount: $224,985.00DESCRIPTION provided by applicant It is believed that emergent stem cell based therapies are destined to replace islet transplantation in the near future The first wave of next generation cell the ...SBIRPhase I2015Department of Health and Human Services National Institutes of HealthA perfluorocarbon-based culture device for beta cell biology applications (Phase
Amount: $993,620.00ABSTRACT Conventional culture vessels are not designed for physiological oxygen delivery. Both hyperoxia and hypoxia - commonly observed when culturing cells and tissues in regular plasticware- have ...SBIRPhase II2012Department of Health and Human Services
No comments:
Post a Comment